Cellular activities in the regulation of growth or adhesion/migration involve protein (lectin)-carbohydrate recognition at the cell surface. Members of the galectin family of endogenous lectins additionally bind distinct intracellular ligands. These interactions with protein targets explain the relevance of their nuclear and cytoplasmic presence. Expression profiling for galectins and accessible binding sites is a histochemical approach to link localization with cellular growth properties. Non-cross-reactive antibodies for the homodimeric (proto-type) galectins-1, -2 and -7 and the chimera-type galectin-3 (Gal-3) as well as the biotinylated lectins were tested. This analysis was performed with the FaDu squamous carcinoma cell line and long-term cultured human and porcine epidermal cells as models for malignant and normal cells of squamous cell epithelial origin. A set of antibodies was added for phenotypic cell characterization. Strong nuclear and cytoplasmic signals of galectins and the differential reactivity of labeled galectins support the notion of their individual properties. The length of the period of culture was effective in modulating marker expression. Cytochemical expression profiling is a prerequisite for the selection of distinct proteins for targeted modulation of gene expression as a step toward functional analysis.

Institute of Anatomy 1st Faculty of Medicine Charles University U nemocnice 3 128 00 Prague 2 Czech Republic

Zobrazit více v PubMed

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11329-34 PubMed

Biophys J. 2003 Jul;85(1):511-24 PubMed

J Mol Histol. 2005 Feb;36(1-2):89-96 PubMed

Exp Cell Res. 1997 May 1;232(2):216-24 PubMed

Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11830-5 PubMed

Nature. 1997 Sep 18;389(6648):300-5 PubMed

Cancer. 2003 Apr 15;97(8):1849-58 PubMed

Cancer Res. 2005 May 1;65(9):3535-7 PubMed

Glycoconj J. 2001 Aug;18(8):589-613 PubMed

Cancer. 1999 Dec 1;86(11):2353-63 PubMed

Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;52(2):107-15 PubMed

J Cancer Res Clin Oncol. 2001;127(6):375-86 PubMed

Anat Histol Embryol. 2001 Feb;30(1):3-31 PubMed

Differentiation. 2004 Oct;72(8):387-95 PubMed

Am J Dermatopathol. 2004 Oct;26(5):372-8 PubMed

Cancer Sci. 2003 May;94(5):425-30 PubMed

Eur J Biochem. 2004 Jan;271(1):118-34 PubMed

Cell Mol Life Sci. 1999 Mar;55(3):368-422 PubMed

Pigment Cell Res. 2001 Jun;14(3):185-94 PubMed

Exp Cell Res. 1998 Aug 1;242(2):419-28 PubMed

Genes Dev. 2004 Jan 15;18(2):126-31 PubMed

Mech Dev. 2001 Dec;109(2):173-81 PubMed

J Immunol. 2004 Sep 15;173(6):3825-37 PubMed

Cancer Res. 1997 Sep 15;57(18):4111-7 PubMed

Dev Dyn. 2005 Feb;232(2):293-300 PubMed

Arch Dermatol Res. 1991;283(3):174-9 PubMed

Biol Cell. 1991;73(1):35-42 PubMed

Glycoconj J. 2004;20(4):227-38 PubMed

Cells Tissues Organs. 2001;168(1-2):5-23 PubMed

FASEB J. 2004 Oct;18(13):1556-8 PubMed

J Invest Dermatol. 2001 Aug;117(2):205-13 PubMed

J Biol Chem. 1995 Mar 17;270(11):5823-9 PubMed

Int J Mol Med. 2000 Apr;5(4):369-72 PubMed

Anticancer Res. 1990 Nov-Dec;10(6):1627-31 PubMed

Biochim Biophys Acta. 2002 Sep 19;1572(2-3):274-84 PubMed

Acta Anat (Basel). 1998;161(1-4):162-79 PubMed

Biochimie. 2004 Apr-May;86(4-5):317-26 PubMed

Glycoconj J. 2004;19(7-9):499-506 PubMed

Chembiochem. 2004 Jun 7;5(6):740-64 PubMed

Biochemistry. 2003 Dec 23;42(50):14762-73 PubMed

Proteomics. 2004 Aug;4(8):2465-75 PubMed

Biol Cell. 2003 Nov;95(8):535-45 PubMed

Stem Cells. 2003;21(6):661-9 PubMed

Histol Histopathol. 2001 Jul;16(3):861-8 PubMed

Bioconjug Chem. 2004 Jan-Feb;15(1):87-98 PubMed

J Cell Biol. 2005 May 9;169(3):491-501 PubMed

Nature. 1990 Feb 1;343(6257):437-41 PubMed

J Biol Chem. 1993 Jul 15;268(20):14932-9 PubMed

Clin Cancer Res. 2005 Apr 1;11(7):2471-7 PubMed

Cancer Res. 2004 Aug 15;64(16):5672-6 PubMed

J Dermatol Sci. 2002 Apr;28(3):173-80 PubMed

Cell Tissue Res. 2002 Jan;307(1):35-46 PubMed

Crit Rev Oncol Hematol. 2004 Jul;51(1):1-28 PubMed

Mol Carcinog. 1997 Oct;20(2):204-15 PubMed

Int J Cancer. 2005 Mar 10;114(1):46-57 PubMed

Biochim Biophys Acta. 2002 Sep 19;1572(2-3):209-31 PubMed

J Invest Dermatol. 2005 Feb;124(2):367-72 PubMed

Histol Histopathol. 2000 Jan;15(1):85-94 PubMed

J Cell Biol. 1986 Feb;102(2):477-83 PubMed

Cancer Res. 2004 May 1;64(9):3112-8 PubMed

Anat Rec. 1995 Jun;242(2):211-9 PubMed

Biochem Biophys Res Commun. 2001 Dec 14;289(4):845-50 PubMed

Folia Biol (Praha). 1999;45(4):157-62 PubMed

J Biol Chem. 2001 Sep 21;276(38):35917-23 PubMed

Nature. 2004 May 6;429(6987):72-5 PubMed

Histol Histopathol. 2003 Jul;18(3):771-9 PubMed

Nucleic Acids Res. 2001 Sep 1;29(17 ):3595-602 PubMed

Exp Cell Res. 1995 Oct;220(2):397-406 PubMed

Mod Pathol. 2002 Dec;15(12):1294-301 PubMed

Biochem J. 2004 May 15;380(Pt 1):31-41 PubMed

Glycoconj J. 2004;20(4):247-55 PubMed

Biochim Biophys Acta. 2002 Sep 19;1572(2-3):232-54 PubMed

J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):461-74 PubMed

APMIS. 2002 Dec;110(12):845-56 PubMed

Leukemia. 2002 May;16(5):840-5 PubMed

Nat Rev Cancer. 2005 Jan;5(1):29-41 PubMed

Int J Cancer. 2004 Sep 20;111(5):662-8 PubMed

Eur J Cancer. 2004 Oct;40(15):2324-30 PubMed

Biochemistry. 1996 May 14;35(19):6073-9 PubMed

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3156-61 PubMed

Biochem Biophys Res Commun. 2003 Mar 14;302(3):545-53 PubMed

J Invest Dermatol. 2001 May;116(5):633-40 PubMed

Eur J Biochem. 1997 Feb 1;243(3):543-76 PubMed

Circulation. 2004 Nov 9;110(19):3121-8 PubMed

Differentiation. 1998 Jul;63(3):159-68 PubMed

J Mol Biol. 2004 Oct 29;343(4):957-70 PubMed

Cell Mol Life Sci. 2004 May;61(10):1198-207 PubMed

Int J Oncol. 2001 Jul;19(1):59-64 PubMed

Anat Histol Embryol. 2004 Dec;33(6):348-54 PubMed

J Invest Dermatol. 2000 Mar;114(3):413-20 PubMed

Oncogene. 2002 Nov 14;21(52):8001-10 PubMed